Viridian Therapeutics, Inc. VRDN Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s common stock shares issued?
- Viridian Therapeutics, Inc. (VRDN) reported common stock shares issued of 102.5M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s common stock shares issued changed year-over-year?
- Viridian Therapeutics, Inc.'s common stock shares issued increased by 25.6% year-over-year, from 81.6M to 102.5M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s common stock shares issued?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s common stock shares issued has grown at a 88.9% compound annual growth rate (CAGR), from 4.2M to 101.8M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.